MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
MRC Tropical Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Lancet Infect Dis. 2018 Jun;18(6):640-649. doi: 10.1016/S1473-3099(18)30172-5. Epub 2018 Apr 9.
Scale-up of insecticide-based interventions has averted more than 500 million malaria cases since 2000. Increasing insecticide resistance could herald a rebound in disease and mortality. We aimed to investigate whether insecticide resistance was associated with loss of effectiveness of long-lasting insecticidal nets and increased malaria disease burden.
This WHO-coordinated, prospective, observational cohort study was done at 279 clusters (villages or groups of villages in which phenotypic resistance was measurable) in Benin, Cameroon, India, Kenya, and Sudan. Pyrethroid long-lasting insecticidal nets were the principal form of malaria vector control in all study areas; in Sudan this approach was supplemented by indoor residual spraying. Cohorts of children from randomly selected households in each cluster were recruited and followed up by community health workers to measure incidence of clinical malaria and prevalence of infection. Mosquitoes were assessed for susceptibility to pyrethroids using the standard WHO bioassay test. Country-specific results were combined using meta-analysis.
Between June 2, 2012, and Nov 4, 2016, 40 000 children were enrolled and assessed for clinical incidence during 1·4 million follow-up visits. 80 000 mosquitoes were assessed for insecticide resistance. Long-lasting insecticidal net users had lower infection prevalence (adjusted odds ratio [OR] 0·63, 95% CI 0·51-0·78) and disease incidence (adjusted rate ratio [RR] 0·62, 0·41-0·94) than did non-users across a range of resistance levels. We found no evidence of an association between insecticide resistance and infection prevalence (adjusted OR 0·86, 0·70-1·06) or incidence (adjusted RR 0·89, 0·72-1·10). Users of nets, although significantly better protected than non-users, were nevertheless subject to high malaria infection risk (ranging from an average incidence in net users of 0·023, [95% CI 0·016-0·033] per person-year in India, to 0·80 [0·65-0·97] per person year in Kenya; and an average infection prevalence in net users of 0·8% [0·5-1·3] in India to an average infection prevalence of 50·8% [43·4-58·2] in Benin).
Irrespective of resistance, populations in malaria endemic areas should continue to use long-lasting insecticidal nets to reduce their risk of infection. As nets provide only partial protection, the development of additional vector control tools should be prioritised to reduce the unacceptably high malaria burden.
Bill & Melinda Gates Foundation, UK Medical Research Council, and UK Department for International Development.
自 2000 年以来,杀虫剂干预措施的推广已避免了超过 5 亿例疟疾病例。杀虫剂抗性的增加可能预示着疾病和死亡率的反弹。我们旨在调查杀虫剂抗性是否与长效杀虫蚊帐有效性的丧失和疟疾负担的增加有关。
本研究由世卫组织协调,是一项前瞻性观察队列研究,在贝宁、喀麦隆、印度、肯尼亚和苏丹的 279 个群(可衡量表型抗性的村庄或村庄群)进行。拟除虫菊酯长效蚊帐是所有研究地区疟疾媒介控制的主要形式;在苏丹,这种方法还辅以室内滞留喷洒。每个群中的随机选择家庭的儿童被招募并由社区卫生工作者进行随访,以测量临床疟疾的发病率和感染的流行率。使用标准的世卫组织生物测定试验评估蚊子对拟除虫菊酯的敏感性。使用荟萃分析合并各国的结果。
在 2012 年 6 月 2 日至 2016 年 11 月 4 日期间,共招募了 4 万名儿童,并在 140 万次随访中评估了临床发病率。评估了 8 万只蚊子的抗药性。与非使用者相比,长效杀虫蚊帐使用者的感染率(调整后的优势比 [OR] 0.63,95%CI 0.51-0.78)和疾病发生率(调整后的发病率比 [RR] 0.62,0.41-0.94)较低。我们没有发现杀虫剂抗性与感染率(调整后的 OR 0.86,0.70-1.06)或发病率(调整后的 RR 0.89,0.72-1.10)之间存在关联的证据。尽管蚊帐使用者的保护效果明显优于非使用者,但他们仍然面临着高疟疾感染风险(从印度蚊帐使用者的平均发病率为 0.023(每 1000 人年为 0.016-0.033)到肯尼亚为 0.80(0.65-0.97),从印度蚊帐使用者的平均感染率为 0.8%(0.5-1.3)到贝宁的平均感染率为 50.8%(43.4-58.2))。
无论是否存在抗药性,疟疾流行地区的人群都应继续使用长效杀虫蚊帐,以降低感染风险。由于蚊帐只能提供部分保护,应优先开发其他病媒控制工具,以降低无法接受的高疟疾负担。
比尔和梅林达·盖茨基金会、英国医学研究理事会和英国国际发展部。